Alex Brill Interviewed on Future of US Biosimilars Market In a new BioWorld article, Mari Serebrov discusses efforts by Congress to control US prescription drug prices. Interviewed for the article was MGA’s Alex Brill, who talks about the potential side effects...
Shared Savings Models Could Yield Part B Savings Skylar Jeremias | The Center for Biosimilars “The establishment of a shared savings model has the potential to increase health care savings, biologic competition, and biosimilar utilization if implemented in...
New MGA Report on a Medicare Shared Savings Demonstration for Biosimilars Matrix Global Advisors (MGA) today released a new report, “Shared Savings Demonstration for Biosimilars in Medicare: An Opportunity to Promote Biologic Drug Competition,” by MGA...
